NAV-240

· Navigator Medicines, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NAV-240, covering 2025-06-17 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study on the Safety, Tolerability, Bioavailability and Mechanism of Action of Intravenous NAV-240 in Adults. [Phase 1]

See pricing